ligstroside and Diabetes-Mellitus--Type-2

ligstroside has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

Other Studies

1 other study(ies) available for ligstroside and Diabetes-Mellitus--Type-2

ArticleYear
The involvement of phenolic-rich extracts from Galician autochthonous extra-virgin olive oils against the α-glucosidase and α-amylase inhibition.
    Food research international (Ottawa, Ont.), 2019, Volume: 116

    'Brava' and 'Mansa de Figueiredo' extra-virgin olive oils (EVOOs) are two varieties identified from north-western Spain. A systematic phenolic characterization of the studied oils was undertaken by LC-ESI-IT-MS. In addition, the role of dietary polyphenols from these EVOOs has been evaluated against the inhibition of key enzymes (α-glucosidase and α-amylase) in the management of diabetes mellitus (DM). Oleuropein and ligstroside derivatives comprised 83% and 67% of the total phenolic compounds in 'Brava' and 'Mansa de Figueiredo' EVOOs, respectively. The main secoiridoids from oleuropein were DOA (3,4-DHPEA-EDA, 59 and 22 mg kg

    Topics: Aldehydes; alpha-Amylases; alpha-Glucosidases; Cyclopentane Monoterpenes; Diabetes Mellitus, Type 2; Flavonoids; Glucosides; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Iridoid Glucosides; Iridoids; Olive Oil; Phenols; Plant Extracts; Pyrans; Spain

2019